Related Experiment Video
Updated: Jul 9, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
[PDCD5 induces the apoptosis of human prostate cancer cells PC-3M-1E8]
Shu-jun Li1, Jing Yu, Xue-fei Zhao
1Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongiiang 150081, China.
Objective:
To investigate the apoptosis-promoting effect of PDCD5 on human prostate cancer cells PC-3M-1E8.
Methods:
PCI-neo and PCI-neo-PDCD5 were transfected into PC-3M-1E8 cells by Lipofectamine 2000, the viability of the cells was analyzed by MTT assay 16 hours after removal of the serum, and the apoptosis was determined by in situ end-labeling and electron microscopy.
Results:
The viability and growing speed of the transfected cells were significantly decreased and their apoptotic indexes significantly increased as compared with the control group (P < 0.001).
Conclusion:
PDCD5 may significantly inhibit the in vitro growth and promote the apoptosis of human prostate cancer cells PC-3M-1E8.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017